Drug Trial Radar · NCT05741294
A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Last checked: Nov 20, 2026Latest source record: Feb 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
334
Actual
Start
Jan 20, 2023
Primary completion
Jan 19, 2024
Study completion Jan 19, 2024
Sponsor
- Lead sponsor
- Almirall, S.A.Industry
- Sponsor type
- Industry
- First posted
- Feb 23, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess treatment satisfaction on Day 57 in participants with Actinic Keratoses (AK) of the face or scalp following treatment with tirbanibulin ointment 1 percent (%) administered once daily for 5 consecutive days.
Conditions
- Actinic Keratosis
Interventions
Tirbanibulin 2.5 mg ointmentDrug
Participants will apply tirbanibulin 2.5 mg ointment topically for 5 consecutive days over 25 square centimeters (cm\^2) of the face or scalp.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment Satisfaction Questionnaire for Medication Version 9 (TSQM-9) Total Score of Each Components at Day 57Time frame: At Day 57
Locations
37 sites in 2 countries. Site status is shown where the registry gives one.
Almirall Investigational Site 1
Cagliari, Italy
Almirall Investigational Site 2
Catania, Italy
Almirall Investigational Site 3
Naples, Italy
Almirall Investigational Site 4
Pisa, Italy
Almirall Investigational Site 5
Rimini, Italy
Almirall Investigational Site 6
Torino, Italy
Almirall Investigational Site 7
Trieste, Italy
Almirall Investigational Site 1
Alcorcón, Spain
Almirall Investigational Site 2
Alicante, Spain
Almirall Investigational Site 3
Badalona, Spain
Almirall Investigational Site 4
Barcelona, Spain
Almirall Investigational Site 5
Barcelona, Spain
Almirall Investigational Site 6
Barcelona, Spain
Almirall Investigational Site 7
Barcelona, Spain
Almirall Investigational Site 8
Bilbao, Spain
Almirall Investigational Site 9
Córdoba, Spain
Almirall Investigational Site 10
Fuenlabrada, Spain
Almirall Investigational Site 11
Granada, Spain
Almirall Investigational Site 12
Madrid, Spain
Almirall Investigational Site 13
Madrid, Spain
Almirall Investigational Site 14
Madrid, Spain
Almirall Investigational Site 15
Madrid, Spain
Almirall Investigational Site 16
Majadahonda, Spain
Almirall Investigational Site 17
Málaga, Spain
Almirall Investigational Site 18
Palma, Spain
Almirall Investigational Site 19
Pontevedra, Spain
Almirall Investigational Site 20
Sabadell, Spain
Almirall Investigational Site 21
Salamanca, Spain
Almirall Investigational Site 22
Santa Cruz de Tenerife, Spain
Almirall Investigational Site 23
Seville, Spain
Almirall Investigational Site 24
Seville, Spain
Almirall Investigational Site 25
Valencia, Spain
Almirall Investigational Site 26
Valencia, Spain
Almirall Investigational Site 27
Valencia, Spain
Almirall Investigational Site 28
Vigo, Spain
Almirall Investigational Site 29
Zaragoza, Spain
Almirall Investigational Site 30
Zaragoza, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.